8-Isoprostaglandin E2 Enhances Receptor-activated NFκB Ligand (RANKL)-dependent Osteoclastic Potential of Marrow Hematopoietic Precursors via the cAMP Pathway

This publication has 36 references indexed in Scilit:

• Prostaglandin E₂ increases cyclic AMP and inhibits endothelin‐1 production/secretion by guinea‐pig tracheal epithelial cells through EP₄ receptors
  British Journal of Pharmacology, 2001
• Atherogenic High-Fat Diet Reduces Bone Mineralization in Mice
  Journal of Bone and Mineral Research, 2001
• Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo
  Journal of Biological Chemistry, 1999
• Free-radical–generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells
  Kidney International, 1999
• A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and Function
  Biochemical and Biophysical Research Communications, 1999
• The isoprostanes: Unique bioactive products of lipid peroxidation
  Journal of Biomedical Science, 1998
• Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
  Cell, 1998
• Prostaglandin F₂-Like Compounds, F₂-Isoprostanes, Are Present in Increased Amounts in Human Atherosclerotic Lesions
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Arterial calcification in face of osteoporosis in ageing: can we blame oxidized lipids?
  Current Opinion in Lipidology, 1997
• Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: Role of cAMP-dependent protein kinase
  Journal of Bone and Mineral Research, 1996